IceCure Medical
ICCM
10 hedge funds and large institutions have $245K invested in IceCure Medical in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
187% more capital invested
Capital invested by funds: $85.3K → $245K (+$160K)
25% more funds holding
Funds holding: 8 → 10 (+2)
0.01% more ownership
Funds ownership: 0.01% → 0.01% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$32.1K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$24.1K |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$23.9K |
| 4 |
VF
Virtu Financial
New York
|
+$17.5K |
| 5 |
JP Morgan Chase
New York
|
+$11.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bourgeon Capital Management
Darien,
Connecticut
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Bank of America
Charlotte,
North Carolina
| $85.9K | +$24.1K | +672 | +57% |
|
|
BFM
2
Boothbay Fund Management
New York
| $62K | +$23.9K | +666 | +100% |
|
|
3
UBS Group
Zurich,
Switzerland
| $44.9K | +$32.1K | +897 | +1,300% |
|
|
VF
4
Virtu Financial
New York
| $23K | +$17.5K | +487 | New |
|
|
5
JP Morgan Chase
New York
| $15K | +$11.8K | +330 | New |
|
6
Osaic Holdings
Scottsdale,
Arizona
| $8K | – | – | – |
|
7
Wells Fargo
San Francisco,
California
| $4.81K | +$3.8K | +106 | New |
|
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$215 | +6 | +35% |
|
|
BCWM
9
Bartlett & Co Wealth Management
Cincinnati,
Ohio
| $380 | – | – | – |
|
|
BCM
10
Bourgeon Capital Management
Darien,
Connecticut
| – | -$3K | -90 | Closed |
|
ICCM Hedge Fund Activity: Q4 2022 in Review
10 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q4 2022, worth a combined $245K — up 187% from $85.3K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ICCM positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $32.1K. The largest seller was Bourgeon Capital Management, exiting entirely with an estimated $3K sold.
- 10 institutional investors held IceCure Medical (ICCM) as of Q4 2022, up from 8 in Q3 2022.
- Funds reported $245K of IceCure Medical stock for Q4 2022, up 187% quarter-over-quarter.
- 3 funds opened new IceCure Medical positions in Q4 2022 and 1 closed out, a net change of +2 holders.
- The largest IceCure Medical buyer in Q4 2022 was UBS Group, an estimated $32.1K added.
- The largest IceCure Medical seller in Q4 2022 was Bourgeon Capital Management, an estimated $3K sold.
Based on aggregated 13F filings for Q4 2022.